EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
81 hedge funds and large institutions have $28.9M invested in Eiger BioPharmaceuticals, Inc. in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 28 increasing their positions, 23 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
87% less capital invested
Capital invested by funds: $227M → $28.9M (-$198M)
100% less funds holding in top 10
Funds holding in top 10: 6 → 0 (-6)
Holders
81
Holding in Top 10
–
Calls
$303K
Puts
$48K
Top Buyers
| 1 | +$1.29M | |
| 2 | +$905K | |
| 3 | +$578K | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$573K |
| 5 |
Morgan Stanley
New York
|
+$398K |
Top Sellers
| 1 | -$7.24M | |
| 2 | -$4.22M | |
| 3 | -$4.07M | |
| 4 |
CA
CHI Advisors
New York
|
-$3.43M |
| 5 |
ACM
Altium Capital Management
New York
|
-$3.31M |